Result Summaries: GSK1557484
| GSK Study ID |
Phase | Title | Summary (Download) |
|---|---|---|---|
| 111756 | Phase 2 | Immunogenicity and safety of GSK Biologicals’ (pre-) pandemic influenza candidate vaccine GSK 1557484A. (0 citation(s)) |  |
| GSK Study ID |
Phase | Title | Summary (Download) |
|---|---|---|---|
| 111756 | Phase 2 | Immunogenicity and safety of GSK Biologicals’ (pre-) pandemic influenza candidate vaccine GSK 1557484A. (0 citation(s)) | |